<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03394768</url>
  </required_header>
  <id_info>
    <org_study_id>2017/2820</org_study_id>
    <secondary_id>CHF2017.08-S</secondary_id>
    <nct_id>NCT03394768</nct_id>
  </id_info>
  <brief_title>Comparison Between NICOM-Cheetah and Flotrac-Vigileo for Cardiac Output Monitoring.</brief_title>
  <official_title>An Observational Study Comparing NICOM-Cheetah Versus Flotrac-Vigileo for Cardiac Output Monitoring in the Surgical Intensive Care Unit.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changi General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac output (CO) monitoring is an important tool in critically ill patients with&#xD;
      haemodynamic instability. Traditionally, this has been accomplished using the pulmonary&#xD;
      artery catheter (PAC). However, its use has been associated with various complications such&#xD;
      as pneumothorax, arrhythmia, infection, pulmonary valve injury and embolism. This has led to&#xD;
      the development of various minimally invasive cardiac output monitoring devices such as the&#xD;
      oesophageal Doppler, PiCCO®, NiCCO® and FloTrac®. These devices however have their inherent&#xD;
      limitations and though minimally invasive, are still not without risks to the patient. More&#xD;
      recently a completely non-invasive CO monitoring device, NICOM Cheetah® has been introduced.&#xD;
      Its use is based on thoracic bioreactance and it involves placement of 4 electrodes on either&#xD;
      side of the thorax and it analyses changes in the phase of electrical voltage signal to the&#xD;
      current applied across the thorax. Initial validation studies on the NICOM Cheetah® device&#xD;
      revealed promising results. This study intends to compare cardiac output monitoring&#xD;
      capabilities of the NICOM Cheetah® device using the FloTrac® CO monitor as a reference.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a single centre prospective observational study. 50 consecutive patients&#xD;
      admitted to the surgical intensive care unit (SICU) who are deemed to require cardiac output&#xD;
      monitoring by the treating intensivist will be studied. Data collection is planned to be&#xD;
      carried out over 2 consecutive years. Inclusion criteria are: 1) Patients who are deemed to&#xD;
      require cardiac output monitoring. 2) Patients 21 years old and above. 3) American Society of&#xD;
      Anesthesiologist (ASA) physical status 1 to 4. Exclusion criteria are: 1) Patients who are&#xD;
      not on mechanical ventilation. 2) Patients who are not in sinus rhythm. 3) Patients with&#xD;
      allergy to adhesive tapes. Patients will be treated as per department protocols and no&#xD;
      additional intervention will be performed. Each patient will have an arterial catheter&#xD;
      inserted as per our usual practice. All patients will have the FloTrac® connected to the&#xD;
      arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on&#xD;
      the skin across the anterior thoracic wall. The FloTrac CO monitor is the current standard of&#xD;
      care for cardiac output monitoring in the SICU of CGH. All patients deemed to require cardiac&#xD;
      output monitoring will receive the FloTrac (as per departmental practice). The NICOM CO&#xD;
      monitor involves the application of non-invasive sensor strips. In this study, it will be&#xD;
      applied to patients receiving the FloTrac (standard of care), on top of the standard care of&#xD;
      monitoring with Flotrac. For each patient, standard demographic and SICU data (age, gender,&#xD;
      comorbidities, ASA score, admission diagnosis, type of surgery, cause of haemodynamic&#xD;
      instability, mean arterial pressure (MAP) and central venous pressure (CVP) at the time of&#xD;
      instituting cardiac output (CO) monitoring, use of inotropic support, presence of renal&#xD;
      replacement therapy, presence of mechanical ventilation and APACHE II score) will be&#xD;
      collected. Cardiac Index (CI) values simultaneously recorded by the NICOM Cheetah® and&#xD;
      FloTrac® on a 15-minutely basis for the first 10-hour period will also be collected. These&#xD;
      data will be automatically recorded by the FloTrac® Vigilance monitor and the Cheetah NICOM&#xD;
      monitor and transcribed to a data entering/analysis software by the principal and&#xD;
      co-principal investigators for data analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim analysis shown futility to continue due to lack of benefit.&#xD;
  </why_stopped>
  <start_date type="Actual">August 10, 2018</start_date>
  <completion_date type="Actual">January 5, 2021</completion_date>
  <primary_completion_date type="Actual">January 5, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Degree of Disagreement, %</measure>
    <time_frame>10 hours of data collected for each participant</time_frame>
    <description>Comparison of cardiac output monitoring capabilities of the NICOM Cheetah® versus the FloTrac®. Cardiac output defined as the amount of blood the heart pumps through the circulatory system in a minute. Bland-Altman analysis used to compare the level of disagreement between the 2 devices, %.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Cardiac Output, Low</condition>
  <arm_group>
    <arm_group_label>NICOM Cheetah®</arm_group_label>
    <description>Patients will be treated as per department protocols and no additional intervention will be performed. Each patient will have an arterial catheter inserted as per our usual practice. All patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The NICOM CO monitor involves the application of non-invasive sensor strips. In this study, it will be applied to patients receiving the FloTrac (standard of care), on top of the standard care of monitoring with Flotrac.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FloTrac®</arm_group_label>
    <description>Same patient population as the NICOM Cheetah® group as described above as all patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The FloTrac CO monitor is the current standard of care for cardiac output monitoring in the SICU of CGH. All patients deemed to require cardiac output monitoring will receive the FloTrac (as per departmental practice).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No additional intervention</intervention_name>
    <description>Patients will be treated as per department protocols and no additional intervention will be performed</description>
    <arm_group_label>FloTrac®</arm_group_label>
    <arm_group_label>NICOM Cheetah®</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the surgical intensive care unit (SICU) who are deemed to require&#xD;
        cardiac output monitoring by the treating intensivist&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who are deemed to require cardiac output monitoring.&#xD;
&#xD;
          -  Patients 21 years old and above&#xD;
&#xD;
          -  American Society of Anesthesiologist (ASA) physical status 1 to 4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are not on mechanical ventilation.&#xD;
&#xD;
          -  Patients who are not in sinus rhythm.&#xD;
&#xD;
          -  Patients with allergy to adhesive tapes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>See Seong Chang, MBBS, MMed</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changi General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louis Ng, MBBS, ANZCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changi General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Surgical Intensive Care Unit, Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Squara P, Denjean D, Estagnasie P, Brusset A, Dib JC, Dubois C. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med. 2007 Jul;33(7):1191-1194. doi: 10.1007/s00134-007-0640-0. Epub 2007 Apr 26.</citation>
    <PMID>17458538</PMID>
  </reference>
  <reference>
    <citation>Raval NY, Squara P, Cleman M, Yalamanchili K, Winklmaier M, Burkhoff D. Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput. 2008 Apr;22(2):113-9. doi: 10.1007/s10877-008-9112-5. Epub 2008 Mar 14.</citation>
    <PMID>18340540</PMID>
  </reference>
  <reference>
    <citation>Marqué S, Cariou A, Chiche JD, Squara P. Comparison between Flotrac-Vigileo and Bioreactance, a totally noninvasive method for cardiac output monitoring. Crit Care. 2009;13(3):R73. doi: 10.1186/cc7884. Epub 2009 May 19.</citation>
    <PMID>19454009</PMID>
  </reference>
  <reference>
    <citation>Mehta Y, Arora D. Newer methods of cardiac output monitoring. World J Cardiol. 2014 Sep 26;6(9):1022-9. doi: 10.4330/wjc.v6.i9.1022. Review.</citation>
    <PMID>25276302</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 3, 2018</study_first_submitted>
  <study_first_submitted_qc>January 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2018</study_first_posted>
  <results_first_submitted>January 26, 2021</results_first_submitted>
  <results_first_submitted_qc>February 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 3, 2021</results_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changi General Hospital</investigator_affiliation>
    <investigator_full_name>Chang See Seong</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiac Output, Low</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be available to anyone else other than the investigators of this study</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03394768/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants recruited from the surgical intensive care unit of Changi General Hospital, Singapore, from 2018 until 2021</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>All Participants</title>
          <description>Patients will be treated as per department protocols and no additional intervention will be performed. Each patient will have an arterial catheter inserted as per our usual practice. All patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The NICOM CO monitor involves the application of non-invasive sensor strips. In this study, it will be applied to patients receiving the FloTrac (standard of care), on top of the standard care of monitoring with Flotrac.&#xD;
No additional intervention: Patients will be treated as per department protocols and no additional intervention will be performed</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>Patients will be treated as per department protocols and no additional intervention will be performed. Each patient will have an arterial catheter inserted as per our usual practice. All patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The NICOM CO monitor involves the application of non-invasive sensor strips. In this study, it will be applied to patients receiving the FloTrac (standard of care), on top of the standard care of monitoring with Flotrac.&#xD;
No additional intervention: Patients will be treated as per department protocols and no additional intervention will be performed</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.58" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Singapore</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Degree of Disagreement, %</title>
        <description>Comparison of cardiac output monitoring capabilities of the NICOM Cheetah® versus the FloTrac®. Cardiac output defined as the amount of blood the heart pumps through the circulatory system in a minute. Bland-Altman analysis used to compare the level of disagreement between the 2 devices, %.</description>
        <time_frame>10 hours of data collected for each participant</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Participants</title>
            <description>Patients will be treated as per department protocols and no additional intervention will be performed. Each patient will have an arterial catheter inserted as per our usual practice. All patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The NICOM CO monitor involves the application of non-invasive sensor strips. In this study, it will be applied to patients receiving the FloTrac (standard of care), on top of the standard care of monitoring with Flotrac.&#xD;
No additional intervention: Patients will be treated as per department protocols and no additional intervention will be performed</description>
          </group>
        </group_list>
        <measure>
          <title>Degree of Disagreement, %</title>
          <description>Comparison of cardiac output monitoring capabilities of the NICOM Cheetah® versus the FloTrac®. Cardiac output defined as the amount of blood the heart pumps through the circulatory system in a minute. Bland-Altman analysis used to compare the level of disagreement between the 2 devices, %.</description>
          <units>percentage of disagreement</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <desc>All-Cause Mortality, Serious, or Other (non-serious) Adverse Events were monitored/assessed, but none observed.</desc>
      <group_list>
        <group group_id="E1">
          <title>All Participants</title>
          <description>Patients will be treated as per department protocols and no additional intervention will be performed. Each patient will have an arterial catheter inserted as per our usual practice. All patients will have the FloTrac® connected to the arterial catheter (standard of care in CGH SICU) and the NICOM Cheetah® electrodes placed on the skin across the anterior thoracic wall. The NICOM CO monitor involves the application of non-invasive sensor strips. In this study, it will be applied to patients receiving the FloTrac (standard of care), on top of the standard care of monitoring with Flotrac.&#xD;
No additional intervention: Patients will be treated as per department protocols and no additional intervention will be performed</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Serene Yeow, Senior Executive, Clinical Trials and Research Unit</name_or_title>
      <organization>Changi General Hospital</organization>
      <phone>+6581258267 ext +656426781</phone>
      <email>serene_yeow@cgh.com.sg</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

